메뉴 건너뛰기




Volumn 36, Issue 1, 2008, Pages 19-23

Principles of cytotoxic chemotherapy

Author keywords

alkylating agents; anthracyclines; antimetabolites; cancer; chemotherapy; cytotoxic; platinum compounds; tumours

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC ANTIMETABOLITE; ARABINOSIDE; BUSULFAN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CHLORMETHINE DERIVATIVE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DACARBAZINE; DNA TOPOISOMERASE INHIBITOR; FLUOROURACIL; FOLIC ACID ANTAGONIST; IFOSFAMIDE; LOMUSTINE; MELPHALAN; METHOTREXATE; NITROSOUREA DERIVATIVE; PLATINUM COMPLEX; PROTEIN TYROSINE KINASE INHIBITOR; PURINE ANTAGONIST; PYRIMIDINE ANTAGONIST; STREPTOZOCIN; TEMOZOLOMIDE; THYMIDYLATE SYNTHASE INHIBITOR; TROFOSFAMIDE; UNINDEXED DRUG;

EID: 37749007713     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2007.10.003     Document Type: Review
Times cited : (58)

References (7)
  • 1
    • 0027787745 scopus 로고
    • Pharmacokinetics of alkylating agents
    • Lind M.J., and Ardiet C. Pharmacokinetics of alkylating agents. Cancer Surv 17 (1993) 157-188
    • (1993) Cancer Surv , vol.17 , pp. 157-188
    • Lind, M.J.1    Ardiet, C.2
  • 2
    • 11344263608 scopus 로고    scopus 로고
    • Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma
    • Belani C.P. Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma. Semin Oncol 31 suppl 14 (2004) 25-33
    • (2004) Semin Oncol , vol.31 , Issue.SUPPL. 14 , pp. 25-33
    • Belani, C.P.1
  • 3
    • 31644436321 scopus 로고    scopus 로고
    • From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates
    • Walling J. From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates. Invest New Drugs 24 (2006) 37-77
    • (2006) Invest New Drugs , vol.24 , pp. 37-77
    • Walling, J.1
  • 4
    • 0036217711 scopus 로고    scopus 로고
    • Thymidylate synthase: a critical target for cancer chemotherapy
    • Rose M.G., Farrell M.P., and Schmitz J.C. Thymidylate synthase: a critical target for cancer chemotherapy. Clin Colorectal Cancer 1 (2002) 220-229
    • (2002) Clin Colorectal Cancer , vol.1 , pp. 220-229
    • Rose, M.G.1    Farrell, M.P.2    Schmitz, J.C.3
  • 5
    • 0026714331 scopus 로고
    • The anthracyclines: will we ever find a better doxorubicin?
    • Weiss R.B. The anthracyclines: will we ever find a better doxorubicin?. Semin Oncol 9 (1992) 670-686
    • (1992) Semin Oncol , vol.9 , pp. 670-686
    • Weiss, R.B.1
  • 6
    • 33749034730 scopus 로고    scopus 로고
    • Topoisomerase I inhibitors: camptothecins and beyond
    • Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 6 (2006) 789-802
    • (2006) Nat Rev Cancer , vol.6 , pp. 789-802
    • Pommier, Y.1
  • 7
    • 1442283808 scopus 로고    scopus 로고
    • Emerging treatments in oncology: focus on tyrosine kinase (erbB) receptor inhibitors
    • Hamid O. Emerging treatments in oncology: focus on tyrosine kinase (erbB) receptor inhibitors. J Am Pharm Assoc 44 (2004) 52-58
    • (2004) J Am Pharm Assoc , vol.44 , pp. 52-58
    • Hamid, O.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.